530617 — Sampre Nutritions Cashflow Statement
0.000.00%
- IN₹1.28bn
- IN₹1.44bn
- IN₹251.24m
- 21
- 22
- 50
- 18
Annual cashflow statement for Sampre Nutritions, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 1.08 | 3.72 | 4.17 | 4.88 | -75.2 |
Depreciation | |||||
Non-Cash Items | 7.42 | 16.7 | 17.7 | 19 | 14.6 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -28.4 | -12.7 | -31.3 | -2.64 | 41.8 |
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -1.77 | 24.1 | 8.79 | 39.5 | 0.843 |
Capital Expenditures | -23.6 | -13 | -44.1 | -37.1 | -2.77 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 14.6 | 5.37 | 0.897 | 0.095 | -749 |
Sale of Fixed Assets | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -8.99 | -7.65 | -43.2 | -37 | -752 |
Financing Cash Flow Items | -7.42 | -16.7 | -17.8 | -19 | -17 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 3.26 | -16.6 | 34.8 | -0.945 | 750 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -7.5 | -0.148 | 0.434 | 1.59 | -0.528 |